HNAC Technology (300490.SZ) issues a profit warning, expecting a net loss of 360 million to 420 million yuan for the fiscal year 2024, with the loss widening.

20/01/2025

GMT Eight

HNAC Technology (300490.SZ) releases 2024 performance forecast, with the company expecting a net loss attributable to shareholders of the listed company of 3.6 billion to 4.2 billion yuan in 2024, with the loss expanding; and a net loss of 3.89 billion to 4.49 billion yuan after deducting non-recurring gains and losses, with the loss expanding.

Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) announced a pre-reduction, with an expected annual net profit of 14.5 to 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%.

Huadong Medicine (000963.SZ): Medical device MediBeacon TGFR for evaluating kidney function approved by the U.S. FDA.

Contact: contact@gmteight.com

HNAC Technology (300490.SZ) issues a profit warning, expecting a net loss of 360 million to 420 million yuan for the fiscal year 2024, with the loss widening.

RECOMMEND

HK ASIA HLDGS(01723) plans to change its name to "Evermoon Holdings Limited"

HK ASIA HLDGS (01723) got a discount of about 5.26% to complete the full purchase offer and resume trading on January 21.

METASURFACE (08637) Controlling shareholder Caina Technology reward plan, and a total of 9.75 million shares of bonus shares granted under the share incentive plan.